Skip to main content
OpenTrials

Clinical trial condition

Antipsychotic-induced Weight Gain (AIWG)

Explore clinical trials studying Antipsychotic-induced Weight Gain (AIWG). Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Antipsychotic-induced Weight Gain (AIWG) trial results

Completed

A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications

NCT03818256

Conditions
Antipsychotic-induced Weight Gain (AIWG), Bipolar Disorder, Bipolar and Related Disorders, +14 more
Locations
  • Site 143 Bentonville, Arkansas, United States
  • Site 249 Little Rock, Arkansas, United States
  • Site 153 Culver City, California, United States
  • Site 239 Garden Grove, California, United States
View all 27 locations
View Trial Details
Completed

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

NCT04524403

Conditions
Antipsychotic-induced Weight Gain (AIWG), Body Weight, Body Weight Changes, +11 more
Locations
  • Site #143 Bentonville, Arkansas, United States
  • Site # 249 Little Rock, Arkansas, United States
  • Site #153 Culver City, California, United States
  • Site #239 Garden Grove, California, United States
View all 40 locations
View Trial Details

Related conditions